MarketCap
Facebook
X
TelegramAnnual report 2024
added 12-27-2025
OrganiGram Holdings Operating Cash Flow 2011-2026 | OGI
Annual Operating Cash Flow OrganiGram Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | -28.6 M | -45.1 M | -35.1 M | -12.7 M | - | - | - | - | - | - | - |
All numbers in CAD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -12.7 M | -45.1 M | -30.4 M |
Operating Cash Flow of other stocks in the Drug manufacturers industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
-11.4 M | - | 7.5 % | $ 6.35 M |  USA |
 |
Aerie Pharmaceuticals
AERI
|
-99.2 M | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
-9.58 M | - | 10.11 % | $ 58.2 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-25.9 M | - | 0.86 % | $ 117 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-612 K | $ 4.19 | 3.2 % | $ 58.9 M | USA |
 |
Catalent
CTLT
|
268 M | - | - | $ 11.5 B | USA |
 |
Alimera Sciences
ALIM
|
-14.3 M | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
-131 M | - | -23.39 % | $ 1.76 M | USA |
 |
DURECT Corporation
DRRX
|
-34.4 M | - | - | $ 50.1 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-88 K | $ 1.11 | -2.63 % | $ 1.38 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
50.7 M | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
435 M | - | - | $ 28.9 M |  Irlanda |
 |
Avadel Pharmaceuticals plc
AVDL
|
-46.9 M | - | - | $ 2.06 B |  France |
 |
Evoke Pharma
EVOK
|
-4.98 M | - | - | $ 36.6 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-462 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
Tilray
TLRY
|
7.91 M | $ 6.89 | 2.07 % | $ 4.26 B |  Canada |
 |
HEXO Corp.
HEXO
|
-43.1 M | - | 2.45 % | $ 38.1 M | Canada |
 |
Bausch Health Companies
BHC
|
1.03 B | $ 5.58 | -0.89 % | $ 2.04 B | Canada |
 |
Jupiter Wellness
JUPW
|
-7.57 M | - | - | $ 33.6 M | USA |
 |
Veru
VERU
|
-21.7 M | $ 2.34 | -0.43 % | $ 316 M | USA |
 |
Canopy Growth Corporation
CGC
|
-166 M | $ 1.2 | 1.27 % | $ 129 M | Canada |
 |
Harrow Health
HROW
|
43.9 M | - | - | $ 1.53 B | USA |
 |
Viatris
VTRS
|
2.9 B | $ 14.81 | 1.51 % | $ 17.8 B | USA |
 |
Lannett Company
LCI
|
-7.12 M | - | 1.15 % | $ 7.11 M | USA |
 |
Solid Biosciences
SLDB
|
-156 M | $ 7.5 | -5.3 % | $ 656 M | USA |
 |
Organogenesis Holdings
ORGO
|
14.2 M | $ 2.39 | 1.7 % | $ 315 M | USA |
 |
Evolus
EOLS
|
-42.3 M | $ 5.22 | -1.51 % | $ 337 M | USA |
 |
Sundial Growers
SNDL
|
-155 M | $ 1.51 | - | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
-206 M | $ 8.03 | - | $ 411 M | USA |
 |
Pacira BioSciences
PCRX
|
189 M | $ 25.55 | 4.24 % | $ 1.18 B | USA |
 |
Neoleukin Therapeutics
NLTX
|
-77.2 M | - | - | $ 193 M | Canada |
 |
ProPhase Labs
PRPH
|
28.6 M | - | - | $ 5.07 M | USA |
 |
cbdMD
YCBD
|
-353 K | $ 0.97 | -3.96 % | $ 4.18 M | USA |
 |
Radius Health
RDUS
|
-22.4 M | - | - | $ 1.42 B | USA |
 |
Assertio Holdings
ASRT
|
-28.2 M | $ 18.04 | - | $ 116 M | USA |
 |
PetIQ
PETQ
|
61.9 M | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
-45.8 M | $ 7.03 | -2.5 % | $ 278 M | USA |
 |
Recro Pharma
REPH
|
-1 M | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
-20.5 M | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
-5.28 M | $ 1.0 | -1.96 % | $ 49.9 M | USA |
 |
PLx Pharma
PLXP
|
-32.1 M | - | -27.8 % | $ 2.56 M | USA |
 |
Aurora Cannabis
ACB
|
-211 M | $ 3.51 | 3.54 % | $ 86.3 M | Canada |
 |
Zomedica Corp.
ZOM
|
-17.6 M | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-23 M | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
-659 K | $ 0.85 | -3.09 % | $ 30.6 M | USA |
 |
Tricida
TCDA
|
-140 M | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
148 K | $ 0.59 | -6.53 % | $ 2.53 M |  China |
 |
TherapeuticsMD
TXMD
|
-159 M | $ 2.07 | -5.48 % | $ 23.9 M | USA |